Overtreatment of men with low‐risk prostate cancer and significant comorbidity

Abstract

Men with significant comorbidity often were overtreated for low-risk prostate cancer. Like advanced age, significant comorbidity should be a strong relative contraindication to aggressive treatment in men with low-risk disease.